Dr. Lauren Rabinovic Joins GLS Capital as Principal

GLS Capital, LLC is pleased to announce that Dr. Lauren Rabinovic has joined the firm as a Principal.   Dr. Rabinovic joins GLS from Abbott Laboratories where she served as Divisional Vice President & Associate General Counsel for IP Strategy.  Prior to Abbott, Dr. Rabinovic spent more than nine years at Teva Pharmaceuticals as Vice President & General Counsel, North Americas Generic IP, where she was responsible for the intellectual property aspects of all of Teva’s U.S. and Canada-based generic products.  Dr. Rabinovic started her legal career as an associate at Foley Hoag and Woodcock Washburn, where she focused on life sciences-related patent litigation.

“We are excited to welcome Lauren to the GLS team. She brings a tremendous amount of experience in the pharmaceutical and medical device industries,” said Jamison Lynch, Managing Director of GLS.  “Lauren’s exceptional professional accomplishments and educational background are an excellent match for GLS as we continue to build out our team.”

Dr. Rabinovic earned a B.S. in Biology from the University of Michigan, Ann Arbor, a Ph.D. in Neuroscience from the University of Pittsburgh and her J.D. from the Boston University School of Law.

About GLS Capital

Formed in 2018, GLS Capital is one of the world’s largest private investment firms focused on legal and regulatory risk. We provide bespoke financial solutions to meet the unique needs of each investment opportunity. For more information, please visit: www.glscap.com

Skip to content